Clinical trial
Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
NCT00184665 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00184665 |
|---|---|
| Title | Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes |
| Official title | 2 Year Efficiency and Safety Comparison of Insulin Detemir and NPH Insulin in Type 1 Diabetes. |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin detemir, insulin NPH, insulin aspart |
| Enrollment | 501 |
| Start date | Jun 1, 2004 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 27, 2017 |
| Countries | Argentina, Australia, Bulgaria, Croatia, India, Malaysia, North Macedonia, Romania, South Africa, Turkey (Türkiye) |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: